Association between muscle strength and echogenicity using greyscale ultrasound software: a diagnostic accuracy study in kidney transplant candidates.

Carolina Acu��a-Pardo, Elena Mu��oz-Redondo, Lou Delcros-Forestier, Yulibeth G Curbelo, Carlos Rodr��guez-Hern��ndez, Delky Meza-Valderrama, Dolores S��nchez-Rodr��guez, Julio Pascual, Maria J P��rez-S��ez, Ester Marco
Author Information
  1. Carolina Acu��a-Pardo: Department of Physical Medicine and Rehabilitation, Hospital del Mar, Barcelona, Spain.
  2. Elena Mu��oz-Redondo: Department of Physical Medicine and Rehabilitation, Hospital del Mar, Barcelona, Spain.
  3. Lou Delcros-Forestier: Department of Physical Medicine and Rehabilitation, Hospital del Mar, Barcelona, Spain.
  4. Yulibeth G Curbelo: Department of Physical Medicine and Rehabilitation, Hospital del Mar, Barcelona, Spain.
  5. Carlos Rodr��guez-Hern��ndez: Department of Physical Medicine and Rehabilitation, Hospital del Mar, Barcelona, Spain.
  6. Delky Meza-Valderrama: Rehabilitation Research Group, Hospital del Mar Research Institute, Barcelona, Spain.
  7. Dolores S��nchez-Rodr��guez: Rehabilitation Research Group, Hospital del Mar Research Institute, Barcelona, Spain.
  8. Julio Pascual: Nephropathies Research Group, Hospital del Mar Research Institute, Barcelona, Spain.
  9. Maria J P��rez-S��ez: Nephropathies Research Group, Hospital del Mar Research Institute, Barcelona, Spain.
  10. Ester Marco: Department of Physical Medicine and Rehabilitation, Hospital del Mar, Barcelona, Spain - emarco@psmar.cat.

Abstract

BACKGROUND: Advanced chronic kidney disease disrupts the delicate equilibrium between protein anabolism and catabolism, leading to alterations in muscle quantity, quality, and function. Musculoskeletal ultrasound emerges as a promising assessment tool due to its widespread availability and high reliability.
AIM: To evaluate the efficacy of rectus femoris (RF) echogenicity, measured using greyscale software, in identifying diminished muscle quality and strength in candidates for kidney transplant.
DESIGN: Post-hoc diagnostic accuracy study.
SETTING: Outpatients in a multimodal prehabilitation program pre kidney transplantation (KT).
POPULATION: patients on the waiting list for KT.
METHODS: Sensitivity, specificity, likelihood ratios and area under the curve (AUC) for diagnostic efficacy of echogenicity (index test) assessed with the ImageJ software greyscale as a potential marker of quadriceps Muscle weakness (reference test) were calculated. Muscle weakness was considered as maximal voluntary isometric contraction of the quadriceps (Q-MVIC) <40% of body weight. Other variables included body composition parameters derived from multifrequency electrical bioimpedance, upper limb muscle strength (handgrip), and RF thickness assessed by ultrasound. Statistical tests: Chi-square, t-Student, Pearson correlation coefficients (r), bivariate and multivariate logistic regression models. Statistical significance level ���0.05.
RESULTS: Of 112 patients (mean age: 63.6, 76% male), 72 (63.7%) exhibited quadriceps weakness, while 80 (70.8%) had some degree of overhydration (extracellular water/total body water ratio >0.390). The echogenicity cut-off point of highest concordance with Muscle weakness was 70, boasting a sensitivity of 83%, specificity of 57%, and AUC of 0.671 (CI 95% 0.570-0.772 [P=0.003]). Echogenicity >70 was associated with a 3.4-fold higher risk of Muscle weakness (crude OR = 3.4 [CI95% 1.4 to 8.0]), which persisted after adjusting for age, height, weight and RF thickness.
CONCLUSIONS: The RF echogenicity exhibits fair validity in identifying Muscle weakness among candidates for KT. However, it cannot be endorsed as a standalone diagnostic tool in this population.
CLINICAL REHABILITATION IMPACT: Early identification of Muscle weakness would advance efforts to mitigate morbidity and mortality through targeted measures.

References

  1. Eur Geriatr Med. 2021 Feb;12(1):45-59 [PMID: 33387359]
  2. J Nephrol. 2021 Aug;34(4):1347-1372 [PMID: 32876940]
  3. J Chiropr Med. 2016 Jun;15(2):155-63 [PMID: 27330520]
  4. BMJ. 1994 Jul 16;309(6948):188 [PMID: 8044101]
  5. Clin Nutr Res. 2015 Jan;4(1):32-40 [PMID: 25713790]
  6. Biometrics. 1977 Jun;33(2):363-74 [PMID: 884196]
  7. Front Med (Lausanne). 2021 May 19;8:675049 [PMID: 34095178]
  8. J Gerontol A Biol Sci Med Sci. 2001 Mar;56(3):M146-56 [PMID: 11253156]
  9. Am J Respir Crit Care Med. 2000 Feb;161(2 Pt 1):487-92 [PMID: 10673190]
  10. Kidney Int. 2016 Jul;90(1):53-66 [PMID: 27157695]
  11. Nutrients. 2024 Jul 12;16(14): [PMID: 39064689]
  12. Muscle Nerve. 2009 Jun;39(6):781-6 [PMID: 19301363]
  13. J Cachexia Sarcopenia Muscle. 2021 Jun;12(3):586-598 [PMID: 33949807]
  14. Clin Kidney J. 2021 Jul 10;15(1):109-118 [PMID: 35035941]
  15. Age Ageing. 2024 Mar 1;53(3): [PMID: 38520141]
  16. Eur Geriatr Med. 2018 Dec;9(6):739-757 [PMID: 34674473]
  17. Clin Nutr. 2021 May;40(5):3052-3061 [PMID: 33183880]
  18. BMC Nephrol. 2019 Mar 28;20(1):105 [PMID: 30922266]
  19. Protein Sci. 2021 Jan;30(1):234-249 [PMID: 33166005]
  20. Age Ageing. 2019 Jan 1;48(1):16-31 [PMID: 30312372]
  21. Am J Respir Crit Care Med. 2002 Jul 1;166(1):111-7 [PMID: 12091180]
  22. Muscle Nerve. 2008 Jul;38(1):893-8 [PMID: 18563722]
  23. Clin Nutr. 2005 Apr;24(2):250-8 [PMID: 15784486]
  24. Rehabilitacion (Madr). 2021 Jan-Mar;55(1):2-4 [PMID: 33077184]
  25. J Rehabil Med. 2021 Jun 21;53(6):jrm00209 [PMID: 34121127]
  26. Clin Chem. 2015 Dec;61(12):1446-52 [PMID: 26510957]
  27. Curr Opin Nephrol Hypertens. 2017 May;26(3):219-228 [PMID: 28198733]

MeSH Term

Humans
Kidney Transplantation
Male
Female
Middle Aged
Ultrasonography
Muscle Strength
Quadriceps Muscle
Muscle Weakness
Software
Adult
Sensitivity and Specificity
Aged
Reproducibility of Results
Hand Strength

Word Cloud

Created with Highcharts 10.0.0muscleweaknessechogenicitykidneyRFdiagnosticultrasoundgreyscalestrengthcandidatesKTquadricepsbodyqualitytoolefficacyusingsoftwareidentifyingtransplantaccuracystudyspecificityAUCtestassessedweightthicknessStatistical6370034BACKGROUND:AdvancedchronicdiseasedisruptsdelicateequilibriumproteinanabolismcatabolismleadingalterationsquantityfunctionMusculoskeletalemergespromisingassessmentduewidespreadavailabilityhighreliabilityAIM:evaluaterectusfemorismeasureddiminishedDESIGN:Post-hocSETTING:OutpatientsmultimodalprehabilitationprogrampretransplantationPOPULATION:PatientswaitinglistMETHODS:SensitivitylikelihoodratiosareacurveindexImageJpotentialmarkerreferencecalculatedMuscleconsideredmaximalvoluntaryisometriccontractionQ-MVIC<40%variablesincludedcompositionparametersderivedmultifrequencyelectricalbioimpedanceupperlimbhandgriptests:Chi-squaret-StudentPearsoncorrelationcoefficientsrbivariatemultivariatelogisticregressionmodelssignificancelevel���005RESULTS:112patientsmeanage:676%male727%exhibited808%degreeoverhydrationextracellularwater/totalwaterratio>0390cut-offpointhighestconcordanceboastingsensitivity83%57%671CI95%570-0772[P=0003]Echogenicity>70associated4-foldhigherriskcrudeOR=[CI95%180]persistedadjustingageheightCONCLUSIONS:exhibitsfairvalidityamongHoweverendorsedstandalonepopulationCLINICALREHABILITATIONIMPACT:EarlyidentificationadvanceeffortsmitigatemorbiditymortalitytargetedmeasuresAssociationsoftware:

Similar Articles

Cited By

No available data.